 Zynerba Pharmaceuticals NASDAQ:ZYNE Inc, a leader in transdermal cannabinoid therapies for rare neuropsychiatric disorders, revealed that it is making an oral podium presentation at the International Society for Autism Researchs four-day annual meeting starting on May 11, 2022. The meeting is being held both in-person and virtually from Austin, Texas. 